Next Article in Journal
Effects of Educating Local Government Officers and Healthcare and Welfare Professionals in Suicide Prevention
Next Article in Special Issue
Non-Genomic Effects of Xenoestrogen Mixtures
Previous Article in Journal
Short and Long Term Variation in Ultraviolet Radiation and Multiple Sclerosis
Article Menu

Export Article

Open AccessReview
Int. J. Environ. Res. Public Health 2012, 9(3), 698-711; doi:10.3390/ijerph9030698

Biomarker Genes for Detecting Estrogenic Activity of Endocrine Disruptors via Estrogen Receptors

Laboratory of Veterinary Biochemistry and Molecular Biology, College of Veterinary Medicine, Chungbuk National University, Cheongju, Chungbuk 361-763, Korea
Author to whom correspondence should be addressed.
Received: 26 December 2011 / Revised: 2 February 2012 / Accepted: 20 February 2012 / Published: 24 February 2012
(This article belongs to the Special Issue Endocrine Disruptors and Human Health)
View Full-Text   |   Download PDF [206 KB, uploaded 19 June 2014]


Endocrine disruptors (EDs) are compounds used in various industrial products, drugs, and cosmetics. They can be found in the environment and disturb the endocrine and reproductive systems, resulting in adverse effects to humans and wildlife such as birth defects and developmental disorders. Since several EDs have a structure similar to that of endogenous steroid hormones such as estrogens, they intend to have an affinity for steroid hormone receptors and alter hormone-mediated metabolism by binding to these receptors. EDs are therefore a global concern and assays should be developed to efficiently determine whether these compounds are detrimental to biological systems. Diverse experimental methods may help determine the endocrine disrupting potential of EDs and evaluate the adverse effects of a single and/or combination of these reagents. Currently, biomarkers have been employed to objectively measure EDs potency and understand the underlying mechanisms. Further studies are required to develop ideal screening methods and biomarkers to determine EDs potency at environmentally relevant concentrations. In this review, we describe the biomarkers for estrogenicity of EDs identified both in vitro and in vivo, and introduce a biomarker, cabindin-D9k (CaBP-9k), that may be used to assess estrogenic activity of EDs. View Full-Text
Keywords: endocrine disruptors; estrogen activity; biomarker; calbindin-D9k endocrine disruptors; estrogen activity; biomarker; calbindin-D9k
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Jung, E.-M.; An, B.-S.; Yang, H.; Choi, K.-C.; Jeung, E.-B. Biomarker Genes for Detecting Estrogenic Activity of Endocrine Disruptors via Estrogen Receptors. Int. J. Environ. Res. Public Health 2012, 9, 698-711.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Environ. Res. Public Health EISSN 1660-4601 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top